When was Biotage founded?

Biotage was founded in 1989 and raised its 1st funding round 26 years after it was founded.

Where is Biotage located?

Biotage is headquartered in Uppsala, Sweden. It is registered at Vimpelgaten 5, SE-753 18 UPPSALA.

Who is the current CEO of Biotage?

Frederic Vanderhaegen of Biotage.

How many employees does Biotage have?

As of Aug 31, 2026, the latest employee count at Biotage is 536.

Is Biotage a funded company?

Biotage is a funded company, having raised an undisclosed amount across 2 funding rounds to date. The company's 1st funding round was a $***** Grant (prize money) round, raised on 2015.

When was the latest funding round of Biotage?

Biotage's latest funding was a $***** Grant (prize money) round on Jan 01, 2017, with participation from 1 investor.

What is the annual revenue of Biotage?

Annual revenue of Biotage is between $100M and $500M as on Dec 31, 2022

Where does Biotage rank among its competitors?

Biotage ranks 12th amongst 373 active competitors, of which 41 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was Biofortuna, which secured $303K in Feb, 2026.

Who are the top competitors of Biotage?

Biotage's top competitors include Novartis, Catalent and Surrozen. Among them, Biofortuna secured the most recent funding round in February, 2026.

Biotage - 2026 Company Profile, Team, Funding, Competitors & Financials

Company Details

Organic synthesis, analytical, and peptide chemistry services for drug discovery and development. It also offers efficient separation technologies from analysis to industrial scale and high quality medical, analytical and peptide chemistry solutions for research and commercial-scale application. The products are utilized by government agencies, academic institutions, pharmaceutical organizations, and food industry entities, among others.

Website: www.biotage.com/
Social
Email ID: *****@biotage.com
Phone Number: +46 **********
Registered Address: Vimpelgaten 5, SE-753 18 UPPSALA

Key Metrics

Founded Year

1989

Location

Uppsala, Sweden

Stage

Acquired

Latest Funding Round

Grant (prize money), Jan 01, 2017, $*****

Investors

Taaleri & 5 more

Ranked

12^th among 373 active competitors

Annual Revenue

$100M - $500M as on Dec 31, 2022

Employee Count

536 as on Aug 31, 2026

Investment & Acquisitions

Astrea Bioseparations & 5 more

Similar Companies

Novartis & 425 more

Exit Details

Acquired by KKR (Apr 22, 2025)

View Biotage's full profile

Biotage is associated with 3 legal entities given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
BIOTAGE SWEDEN AB CIN: 925737402 , Norway, Active	Apr 29, 1994	-	-
Biotage Ab CIN: 556539-3138 , Sweden, Active	Mar 06, 1997	$100M - $500M (As on Dec 31, 2022)	-	-
BIOTAGE INDIA PRIVATE LIMITED CIN: U74999DL2017FTC364509 , India, Active	Oct 11, 2017	₹10 - ₹50 Cr (As on Mar 31, 2025)	14 (As on Aug 01, 2025)

Biotage got acquired by KKR on Apr 22, 2025.

Click here to take a look at Biotage's acquisition in detail

Biotage has raised funding over 2 rounds. Its first funding round was on 2015. Its latest funding round was a Grant (prize money) round on Jan 01, 2017 for $*****. 1 investor participated in its latest round. Biotage has 6 institutional investors.

Here is the list of recent funding rounds of Biotage:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Jan 01, 2017	3704153	Grant (prize money)	1560280	1637096	4921202	9105595
2015	6363	Grant (prize money)	3310	1060	3025	Europa

Access funding benchmarks and valuations. Sign up today!

View details of Biotage's funding rounds and investors

Biotage's employee count trend

Biotage has 536 employees as of Aug 26. Here is Biotage's employee count trend over the years:

Uncover Biotage's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Biotage include Novartis, Catalent and Surrozen. Here is the list of Top 10 competitors of Biotage, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Novartis 1996, Basel (Switzerland), Acquired	R&D focused on manufacturing of drugs for multiple therapeutic areas	-	Digital Pharma Lab, Atlas Venture & 9 others	71/100
2nd	Catalent 2007, Somerset (United States), Acquired	Provider of development, manufacturing, and packaging solutions for medicines and supplements	-	Aisling Capital, JPMorgan Chase & 4 others	68/100
3rd	Surrozen 2016, San Francisco (United States), Public	Pioneering targeted regenerative antibodies to repair tissue and restore organ function	$133M	The Column Group, Horizons Ventures & 13 others	59/100
4th	Biofortuna 2008, Birkenhead (United Kingdom), Series A	Provider of manufacturing services for immunoassays, molecular diagnostics, and regulatory services	$21.6M	Foresight Group, Gov Wales & 12 others	55/100
5th	Acclinate 2020, Birmingham (United States), Series A	Provider of clinical trial services to biopharma sector	$15.5M	Cencora, Alabama Launchpad & 7 others	55/100
6th	Curia 1991, Albany (United States), Acquired	Provider of drug research & development, testing, and consulting services	-	HarbourVest Partners, Thecarlylegroup.fr & 6 others	53/100
7th	Sunflower Therapeutics 2018, Hingham (United States), Series A	Provider of drug development & research services for multiple therapeutic areas	$5.64M	NIAID, Clear Current Capital & 3 others	52/100
8th	WuXi Biologics 2008, Shanghai (China), Public	Developer and manufacturer for protein therapeutics	-	Pivotal bioVenture Partners, HongShan & 3 others	52/100
9th	BioFactura 2004, Frederick (United States), Series B	Biosimilars, biodefense, and biomanufacturing company dedicated to innovation and global biomedical needs	$7.8M	Wilson Sonsini Goodrich & Rosati, UVM Health ... & 2 others	51/100
10th	Ventus Therapeutics 2019, Boston (United States), Series C	Develops small‑molecule therapeutics for autoimmune and auto‑inflammatory diseases treatment	$300M	Versant Ventures, SoftBank Vision Fund & 10 others	51/100
12th	Biotage 1989, Uppsala (Sweden), Acquired	Organic synthesis, analytical, and peptide chemistry services for drug discovery and development	-	Taaleri, Investor Growth Capital & 4 others	49/100

Get insights and benchmarks for competitors of 2M+ companies! Sign up today!

Looking for more details on Biotage's competitors? Click here to see the top ones

Biotage has not made any investments yet. Biotage has made 6 acquisitions.

Here is the list of latest three $acquisitions:

Filter this list

Date of Investment/Acquisition	Type	Company Name	Founded Year	Location
Feb 28, 2023	Acquisition	Astrea Bioseparations	1987	Cambridge (United Kingdom)
Oct 20, 2021	Acquisition	ATDBio	2005	Southampton (United Kingdom)
Dec 04, 2018	Acquisition	PhyNexus	2002	San Jose (United States)